NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center
Trial at the Johns Hopkins Kimmel Cancer Center and other centers finds reduced-intensity haploidentical bone marrow transplant can cure sickle cell disease
Researchers at the Johns Hopkins Kimmel Cancer Center found that the breast tumors of Asian, Black, and white women have very different cellular, microbial, and genomic features and could one day lead to personalized care
During 40 years at Hopkins, Moody Wharam created refined treatments for pediatric cancers that improved survival rates and in some cases remain the standard of care today